GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) » Definitions » Net Margin %

Fuan Pharmaceutical (Group) Co (SZSE:300194) Net Margin % : 15.13% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Fuan Pharmaceutical (Group) Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Fuan Pharmaceutical (Group) Co's Net Income for the three months ended in Mar. 2024 was ¥123 Mil. Fuan Pharmaceutical (Group) Co's Revenue for the three months ended in Mar. 2024 was ¥809 Mil. Therefore, Fuan Pharmaceutical (Group) Co's net margin for the quarter that ended in Mar. 2024 was 15.13%.

The historical rank and industry rank for Fuan Pharmaceutical (Group) Co's Net Margin % or its related term are showing as below:

SZSE:300194' s Net Margin % Range Over the Past 10 Years
Min: -13.49   Med: 9.01   Max: 17.11
Current: 9.7


SZSE:300194's Net Margin % is ranked better than
68.47% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 3.255 vs SZSE:300194: 9.70

Fuan Pharmaceutical (Group) Co Net Margin % Historical Data

The historical data trend for Fuan Pharmaceutical (Group) Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuan Pharmaceutical (Group) Co Net Margin % Chart

Fuan Pharmaceutical (Group) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.53 8.84 -12.10 8.45 8.76

Fuan Pharmaceutical (Group) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.45 11.74 13.90 -3.00 15.13

Competitive Comparison of Fuan Pharmaceutical (Group) Co's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Fuan Pharmaceutical (Group) Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuan Pharmaceutical (Group) Co's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuan Pharmaceutical (Group) Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Fuan Pharmaceutical (Group) Co's Net Margin % falls into.



Fuan Pharmaceutical (Group) Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Fuan Pharmaceutical (Group) Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=231.869/2647.753
=8.76 %

Fuan Pharmaceutical (Group) Co's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=122.5/809.4
=15.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fuan Pharmaceutical (Group) Co  (SZSE:300194) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Fuan Pharmaceutical (Group) Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Fuan Pharmaceutical (Group) Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuan Pharmaceutical (Group) Co (SZSE:300194) Business Description

Traded in Other Exchanges
N/A
Address
No.1 Huanan 1 Road, Changshou District, Chongqing, CHN, 401254
Fuan Pharmaceutical (Group) Co Ltd is mainly engaged in the production and sales of bulk drugs and preparations. The company mainly deals with anti-infective, anti-tumor, mental nervous system, cardiovascular and cerebrovascular, digestive system, endocrine and metabolic, bone and muscle systems. Its products include penicillin and cephalosporins.
Executives
Wu Xiong Hui Executives
Huang Tao Directors, executives
Feng Jing Executives
Yu Xue Song Directors, executives
Hong Rong Chuan Executives
Tang Qin Secretary, Director
Wang Tian Xiang Director
Sun Yong Ping Executives
Jiang Chen Directors, executives
Huang Dao Fei Supervisors
Wen Min Director
Zhou Xu Dong Executives
Zhou Zhong Sheng Supervisors

Fuan Pharmaceutical (Group) Co (SZSE:300194) Headlines

No Headlines